Flu vaccine goes terribly wrong, legal action considered.
Rentrak tells us that the domestic box office is $280M away from matching the 2013 high. Head of Marketplace Trend Paul ...
Share on Pinterest Moderna’s new mRNA flu vaccine has been approved by the FDA for adults ages 50 years and older. FatCamera, E+/Getty Images The Food and Drug Administration (FDA) has approved ...
EL PASO, Texas (KTSM) — The City of El Paso Department of Public Health and the El Paso Fire Department are teaming up once again to put on the Be POWERflu campaign by offering free flu shots to ...
The bizarre-looking Chinese animated film Niu Lai appeared destined to vanish from theaters and take its place among the ...
For older adults, the flu vaccine could look a little different this year. Last week, the US Food and Drug Administration approved the nation’s first mRNA-based flu vaccine for use in people 50 and ...
On 5 August, the US Food and Drug Administration (FDA) granted approval to Moderna’s mRNA-based flu vaccine, mFLUSIVA, for adults aged 50–64, and accelerated approval for adults aged 65 and older.
Flu season typically begins in the fall and peaks during the winter months from December through February. The CDC recommends most people get their flu shot in September or October for optimal ...
Share on Pinterest The FDA approved a new mRNA flu vaccine for older adults ahead of the upcoming 2026–2027 flu season. fotostorm/E+/Getty Images The Food and Drug Administration (FDA) has approved a ...
The United States is finally getting a new type of flu shot. On August 5, the Food and Drug Administration (FDA) approved the mFlusiva vaccine for adults ages 50 and up. Made by biotechnology company ...
After several disastrous flu seasons, there is some good news: The U.S. Food and Drug Administration approved a new, more effective flu vaccine for older adults that should be available in time for ...
See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. The government spent months trying to keep one vaccine off the market, ...